On the other hand, the increased expression of MYH2 in COPD patients may reflect a disease-specific adaptive remodeling of skeletal muscle, supporting its role as a complementary diagnostic marker for COPD-related NAFLD (31–33). This evidence concerns the gene MYH2 and chronic obstructive pulmonary disease.